Newly-Diagnosed, Non-Transplant Eligible Multiple Myeloma Patients: Determinants of Choice of First-Line Treatment in a Single-Center
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2019）
关键词
bortezomib,Lenalidomide,Transplant-ineligible
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要